Systemic TNF blockade does not modulate synovial expression of the pro-inflammatory mediator HMGB1 in rheumatoid arthritis patients - A prospective clinical study

Arthritis Research and Therapy

Volumn 10, Issue 2, 2008, Pages

  Sundberg, Erik ^a   Grundtman, Cecilia ^a   af Klint, Erik ^a   Lindberg, Johan ^b   Ernestam, Sofia ^a   Ulfgren, Ann Kristin ^a   Harris, Helena ^a   Andersson, Ulf ^a  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^b ALBANOVA UNIVERSITY CENTER   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOSPORIN; HIGH MOBILITY GROUP B1 PROTEIN; INFLIXIMAB; MESSENGER RNA; METHOTREXATE; PREDNISONE; TUMOR NECROSIS FACTOR; TUMOR NECROSIS FACTOR ANTIBODY; ANTIRHEUMATIC AGENT; MONOCLONAL ANTIBODY; TUMOR NECROSIS FACTOR ALPHA;

ADULT; AGED; ARTHROSCOPY; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION COEFFICIENT; DISEASE ACTIVITY; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; JOINT BIOPSY; MALE; PROSPECTIVE STUDY; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; RHEUMATOID ARTHRITIS; RNA SYNTHESIS; SCORING SYSTEM; STATISTICAL ANALYSIS; WILCOXON SIGNED RANKS TEST; BIOSYNTHESIS; CLINICAL TRIAL; DRUG ANTAGONISM; DRUG EFFECT; GENE EXPRESSION; KNEE; METABOLISM; MIDDLE AGED; PILOT STUDY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SYNOVIUM;

ADULT; AGED; ANTIBODIES, MONOCLONAL; ANTIRHEUMATIC AGENTS; ARTHRITIS, RHEUMATOID; ARTHROSCOPY; FEMALE; GENE EXPRESSION; HMGB1 PROTEIN; HUMANS; IMMUNOHISTOCHEMISTRY; KNEE JOINT; MALE; MIDDLE AGED; PILOT PROJECTS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; SYNOVIAL MEMBRANE; TUMOR NECROSIS FACTOR-ALPHA;

EID: 42549119565     PISSN: 14786354     EISSN: 14786362     Source Type: Journal    
DOI: 10.1186/ar2387     Document Type: Article

References (53)

1. Maini RN Breedveld FC Kalden JR Smolen JS Davis D Macfarlane JD Antoni C Leeb B Elliott MJ Woody JN Schaible TF Feldmann M Therapeutic efficacy of multiple intravenous infusions of anti-tumor necrosis factor alpha monoclonal antibody combined with low-dose weekly methotrexate in rheumatoid arthritis Arthritis Rheum 1998, 41:1552-1563. 10.1002/ 1529-0131(199809)41:9<1552::AID-ART5>3.0.CO;2-W 9751087
2. Maini RN Breedveld FC Kalden JR Smolen JS Furst D Weisman MH St Clair EW Keenan GF van der Heijde D Marsters PA Lipsky PE Sustained improvement over two years in physical function, structural damage, and signs and symptoms among patients with rheumatoid arthritis treated with infliximab and methotrexate Arthritis Rheum 2004, 50:1051-1065. 10.1002/ art.20159 15077287
3. Klareskog L van der Heijde D de Jager JP Gough A Kalden J Malaise M Martin Mola E Pavelka K Sany J Settas L Wajdula J Pedersen R Fatenejad S Sanda M Therapeutic effect of the combination of etanercept and methotrexate compared with each treatment alone in patients with rheumatoid arthritis: Double-blind randomised controlled trial Lancet 2004, 363:675-681. 10.1016/S0140-6736(04)15640-7 15001324
4. Kokkola R Sundberg E Ulfgren AK Palmblad K Li J Wang H Ulloa L Yang H Yan XJ Furie R Chiorazzi N Tracey KJ Andersson U Harris HE High mobility group box chromosomal protein 1: A novel proinflammatory mediator in synovitis Arthritis Rheum 2002, 46:2598-2603. 10.1002/art.10540 12384917
5. Pullerits R Jonsson IM Verdrengh M Bokarewa M Andersson U Erlandsson-Harris H Tarkowski A High mobility group box chromosomal protein 1, a DNA binding cytokine, induces arthritis Arthritis Rheum 2003, 48:1693-1700. 10.1002/art.11028 12794838
6. Taniguchi N Kawahara K Yone K Hashiguchi T Yamakuchi M Goto M Inoue K Yamada S Ijiri K Matsunaga S Nakajima T Komiya S Maruyama I High mobility group box chromosomal protein 1 plays a role in the pathogenesis of rheumatoid arthritis as a novel cytokine Arthritis Rheum 2003, 48:971-981. 10.1002/art.10859 12687539
7. Andersson U Tracey KJ HMGB1 as a mediator of necrosis-induced inflammation and a therapeutic target in arthritis Rheum Dis Clin North Am 2004, 30:627-637. 10.1016/j.rdc.2004.04.007 15261345
8. Andersson U Erlandsson-Harris H HMGB1 is a potent trigger of arthritis J Intern Med 2004, 255:344-350. 10.1111/j.1365-2796.2003.01303.x 14871458
9. Jiang W Pisetsky DS Mechanisms of Disease: The role of high-mobility group protein 1 in the pathogenesis of inflammatory arthritis Nat Clin Pract Rheumatol 2007, 3:52-58. 10.1038/ncprheum0379 17203009
10. Palmblad K Sundberg E Diez M Soderling R Aveberger AC Andersson U Harris HE Morphological characterization of intra-articular HMGB1 expression during the course of collagen-induced arthritis Arthritis Res Ther 2007, 9:R35. 1906813 17397533 10.1186/ar2155
11. Muller S Scaffidi P Degryse B Bonaldi T Ronfani L Agresti A Beltrame M Bianchi ME New EMBO members' review: The double life of HMGB1 chromatin protein: Architectural factor and extracellular signal Embo J 2001, 20:4337-4340. 125571 11500360 10.1093/emboj/20.16.4337
12. Scaffidi P Misteli T Bianchi ME Release of chromatin protein HMGB1 by necrotic cells triggers inflammation Nature 2002, 418:191-195. 10.1038/ nature00858 12110890
13. Rovere-Querini P Capobianco A Scaffidi P Valentinis B Catalanotti F Giazzon M Dumitriu IE Muller S Iannacone M Traversari C Bianchi ME Manfredi AA HMGB1 is an endogenous immune adjuvant released by necrotic cells EMBO Rep 2004, 5:825-830. 1299116 15272298 10.1038/sj.embor.7400205
14. Dumitriu IE Baruah P Valentinis B Voll RE Herrmann M Nawroth PP Arnold B Bianchi ME Manfredi AA Rovere-Querini P Release of high mobility group box 1 by dendritic cells controls T cell activation via the receptor for advanced glycation end products J Immunol 2005, 174:7506-7515. 15944249
15. Wang H Bloom O Zhang M Vishnubhakat JM Ombrellino M Che J Frazier A Yang H Ivanova S Borovikova L Manogue KR Faist E Abraham E Andersson J Andersson U Molina PE Abumrad NN Sama A Tracey KJ HMG-1 as a late mediator of endotoxin lethality in mice Science 1999, 285:248-251. 10.1126/science.285.5425.248 10398600
16. Andersson U Wang H Palmblad K Aveberger AC Bloom O Erlandsson-Harris H Janson A Kokkola R Zhang M Yang H Tracey KJ High mobility group 1 protein (HMG-1) stimulates proinflammatory cytokine synthesis in human monocytes J Exp Med 2000, 192:565-570. 2193240 10952726 10.1084/ jem.192.4.565
17. Rouhiainen A Kuja-Panula J Wilkman E Pakkanen J Stenfors J Tuominen RK Lepantalo M Carpen O Parkkinen J Rauvala H Regulation of monocyte migration by amphoterin (HMGB1) Blood 2004, 104:1174-1182. 10.1182/ blood-2003-10-3536 15130941
18. Limana F Germani A Zacheo A Kajstura J Di Carlo A Borsellino G Leoni O Palumbo R Battistini L Rastaldo R Muller S Pompilio G Anversa P Bianchi ME Capogrossi MC Exogenous high-mobility group box 1 protein induces myocardial regeneration after infarction via enhanced cardiac C-kit+ cell proliferation and differentiation Circ Res 2005, 97:e73-83. 10.1161/ 01.RES.0000186276.06104.04 16166556
19. Semino C Angelini G Poggi A Rubartelli A NK/iDC interaction results in IL-18 secretion by DCs at the synaptic cleft followed by NK cell activation and release of the DC maturation factor HMGB1 Blood 2005, 106:609-616. 10.1182/blood-2004-10-3906 15802534
20. Gardella S Andrei C Ferrera D Lotti LV Torrisi MR Bianchi ME Rubartelli A The nuclear protein HMGB1 is secreted by monocytes via a non-classical, vesicle-mediated secretory pathway EMBO Rep 2002, 3:995-1001. 1307617 12231511 10.1093/embo-reports/kvf198
21. Bonaldi T Talamo F Scaffidi P Ferrera D Porto A Bachi A Rubartelli A Agresti A Bianchi ME Monocytic cells hyperacetylate chromatin protein HMGB1 to redirect it towards secretion Embo J 2003, 22:5551-5560. 213771 14532127 10.1093/emboj/cdg516
22. Rendon-Mitchell B Ochani M Li J Han J Wang H Yang H Susarla S Czura C Mitchell RA Chen G Sama AE Tracey KJ Wang H IFN-gamma induces high mobility group box 1 protein release partly through a TNF-dependent mechanism J Immunol 2003, 170:3890-3897. 12646658
23. Jiang W Pisetsky DS The role of IFN-alpha and nitric oxide in the release of HMGB1 by RAW 264.7 cells stimulated with polyinosinic-polycytidylic acid or lipopolysaccharide J Immunol 2006, 177:3337-3343. 16920974
24. Kokkola R Andersson A Mullins G Ostberg T Treutiger CJ Arnold B Nawroth P Andersson U Harris RA Harris HE RAGE is the major receptor for the proinflammatory activity of HMGB1 in rodent macrophages Scand J Immunol 2005, 61:1-9. 10.1111/j.0300-9475.2005.01534.x 15644117
25. Park JS Svetkauskaite D He Q Kim JY Strassheim D Ishizaka A Abraham E Involvement of toll-like receptors 2 and 4 in cellular activation by high mobility group box 1 protein J Biol Chem 2004, 279:7370-7377. 10.1074/jbc.M306793200 14660645
26. Yu M Wang H Ding A Golenbock DT Latz E Czura CJ Fenton MJ Tracey KJ Yang H HMGB1 signals through toll-like receptor (TLR) 4 and TLR2 Shock 2006, 26:174-179. 10.1097/01.shk.0000225404.51320.82 16878026
27. Goldstein RS Bruchfeld A Yang L Qureshi AR Gallowitsch-Puerta M Patel NB Huston BJ Chavan S Rosas-Ballina M Gregersen PK Czura CJ Sloan RP Sama AE Tracey KJ Cholinergic anti-inflammatory pathway activity and High Mobility Group Box-1 (HMGB1) serum levels in patients with rheumatoid arthritis Mol Med 2007, 13:210-215. 1899837 17597834 10.2119/ 2006-00108.Goldstein
28. Wang H Yang H Czura CJ Sama AE Tracey KJ HMGB1 as a late mediator of lethal systemic inflammation Am J Respir Crit Care Med 2001, 164:1768-1773. 11734424
29. Kokkola R Li J Sundberg E Aveberger AC Palmblad K Yang H Tracey KJ Andersson U Harris HE Successful treatment of collagen-induced arthritis in mice and rats by targeting extracellular high mobility group box chromosomal protein 1 activity Arthritis Rheum 2003, 48:2052-2058. 10.1002/art.11161 12847700
30. Hofmann MA Drury S Hudson BI Gleason MR Qu W Lu Y Lalla E Chitnis S Monteiro J Stickland MH Bucciarelli LG Moser B Moxley G Itescu S Grant PJ Gregersen PK Stern DM Schmidt AM RAGE and arthritis: The G82S polymorphism amplifies the inflammatory response Genes Immun 2002, 3:123-135. 10.1038/sj.gene.6363861 12070776
31. Van de Wouwer M Plaisance S De Vriese A Waelkens E Collen D Persson J Daha MR Conway EM The lectin-like domain of thrombomodulin interferes with complement activation and protects against arthritis J Thromb Haemost 2006, 4:1813-1824. 10.1111/j.1538-7836.2006.02033.x 16879225
32. Ulloa L Ochani M Yang H Tanovic M Halperin D Yang R Czura CJ Fink MP Tracey KJ Ethyl pyruvate prevents lethality in mice with established lethal sepsis and systemic inflammation Proc Natl Acad Sci USA 2002, 99:12351-12356. 129448 12209006 10.1073/pnas.192222999
33. Chen G Li J Qiang X Czura CJ Ochani M Ochani K Ulloa L Yang H Tracey KJ Wang P Sama AE Wang H Suppression of HMGB1 release by stearoyl lysophosphatidylcholine:aN additional mechanism for its therapeutic effects in experimental sepsis J Lipid Res 2005, 46:623-627. 10.1194/ jlr.C400018-JLR200 15687351
34. Zetterstrom CK Jiang W Wahamaa H Ostberg T Aveberger AC Schierbeck H Lotze MT Andersson U Pisetsky DS Erlandsson Harris H Pivotal advance: inhibition of HMGB1 nuclear translocation as a mechanism for the anti-rheumatic effects of gold sodium thiomalate J Leukoc Biol 2008, 83:31-38. 10.1189/jlb.0507323 17913975
35. Ostberg T Wahamaa H Palmblad K Ito N Stridh P Shoshan M Lotze MT Harris HE Andersson U Oxaliplatin retains HMGB1 intranuclearly and ameliorates collagen type II-induced arthritis Arthritis Res Ther 2008, 10:R1. 10.1186/ar2347 18179697
36. Yang D Chen Q Yang H Tracey KJ Bustin M Oppenheim JJ High mobility group box-1 protein induces the migration and activation of human dendritic cells and acts as an alarmin J Leukoc Biol 2007, 81:59-66. 10.1189/ jlb.0306180 16966386
37. Arnett FC Edworthy SM Bloch DA McShane DJ Fries JF Cooper NS Healey LA Kaplan SR Liang MH Luthra HS The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis Arthritis Rheum 1988, 31:315-324. 10.1002/art.1780310302 3358796
38. Ernestam S af Klint E Catrina AI Sundberg E Engstrom M Klareskog L Ulfgren AK Synovial expression of IL-15 in rheumatoid arthritis is not influenced by blockade of tumour necrosis factor Arthritis Res Ther 2006, 8:R18. 1526582 16507118 10.1186/ar1871
39. Catrina AI af Klint E Ernestam S Catrina SB Makrygiannakis D Botusan IR Klareskog L Ulfgren AK Anti-tumor necrosis factor therapy increases synovial osteoprotegerin expression in rheumatoid arthritis Arthritis Rheum 2006, 54:76-81. 10.1002/art.21528 16385498
40. Wittkowski H Foell D af Klint E De Rycke L De Keyser F Frosch M Ulfgren AK Roth J Effects of intra-articular corticosteroids and anti-TNF therapy on neutrophil activation in rheumatoid arthritis Ann Rheum Dis 2007, 66:1020-1025. 10.1136/ard.2006.061507 17223658
41. Rozen S Skaletsky H Primer3 on the WWW for general users and for biologist programmers Methods Mol Biol 2000, 132:365-386. 10547847
42. Schmittgen TD Real-time quantitative PCR Methods 2001, 25:383-385. 10.1006/meth.2001.1260 11846607
43. Park JS Gamboni-Robertson F He Q Svetkauskaite D Kim JY Strassheim D Sohn JW Yamada S Maruyama I Banerjee A Ishizaka A Abraham E High mobility group box 1 protein interacts with multiple Toll-like receptors Am J Physiol Cell Physiol 2006, 290:C917-924. 10.1152/ajpcell.00401.2005 16267105
44. Liu S Stolz DB Sappington PL Macias CA Killeen ME Tenhunen JJ Delude RL Fink MP HMGB1 is secreted by immunostimulated enterocytes and contributes to cytomix-induced hyperpermeability of Caco-2 monolayers Am J Physiol Cell Physiol 2006, 290:C990-999. 10.1152/ajpcell.00308.2005 16282196
45. Harris HE Raucci A Alarmin(g) news about danger: Workshop on innate danger signals and HMGB1 EMBO Rep 2006, 7:774-778. 1525157 16858429
46. Wahamaa H Vallerskog T Qin S Lunderius C LaRosa G Andersson U Harris HE HMGB1-secreting capacity of multiple cell lineages revealed by a novel HMGB1 ELISPOT assay J Leukoc Biol 2007, 81:129-136. 10.1189/jlb.0506349 16980509
47. Ulfgren AK Andersson U Engstrom M Klareskog L Maini RN Taylor PC Systemic anti-tumor necrosis factor alpha therapy in rheumatoid arthritis down-regulates synovial tumor necrosis factor alpha synthesis Arthritis Rheum 2000, 43:2391-2396. 10.1002/ 1529-0131(200011)43:11<2391::AID-ANR3>3.0.CO;2-F 11083259
48. af Klint E Grundtman C Engstrom M Catrina AI Makrygiannakis D Klareskog L Andersson U Ulfgren AK Intraarticular glucocorticoid treatment reduces inflammation in synovial cell infiltrations more efficiently than in synovial blood vessels Arthritis Rheum 2005, 52:3880-3889. 10.1002/ art.21488 16320336
49. Messmer D Yang H Telusma G Knoll F Li J Messmer B Tracey KJ Chiorazzi N High mobility group box protein 1: An endogenous signal for dendritic cell maturation and Th1 polarization J Immunol 2004, 173:307-313. 15210788
50. Semino C Ceccarelli J Lotti LV Torrisi MR Angelini G Rubartelli A The maturation potential of NK cell clones toward autologous dendritic cells correlates with HMGB1 secretion J Leukoc Biol 2007, 81:92-99. 10.1189/ jlb.0306172 16997859
51. Yamoah K Brebene A Baliram R Inagaki K Dolios G Arabi A Majeed R Amano H Wang R Yanagisawa R Abe E High Mobility Group Box Proteins (HMGBs) Modulate TNF{alpha} Expression in Osteoclastogenesis via a Novel DNA Sequence Mol Endocrinol 2008: Jan 24 18218727
52. Yang H Ochani M Li J Qiang X Tanovic M Harris HE Susarla SM Ulloa L Wang H DiRaimo R Czura CJ Wang H Roth J Warren HS Fink MP Fenton MJ Andersson U Tracey KJ Reversing established sepsis with antagonists of endogenous high-mobility group box 1 Proc Natl Acad Sci USA 2004, 101:296-301. 314179 14695889 10.1073/pnas.2434651100
53. Liu K Mori S Takahashi HK Tomono Y Wake H Kanke T Sato Y Hiraga N Adachi N Yoshino T Nishibori M Anti-high mobility group box 1 monoclonal antibody ameliorates brain infarction induced by transient ischemia in rats Faseb J 2007, 21:3904-3916. 10.1096/fj.07-8770com 17628015